相关实验视频
Updated: May 10, 2025

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
通过向TIGAR,E2F8诱导的GRPEL2促进了结直肠癌的进展
Cheng Song1, Lei Zhao1, Jing Deng1
1Center of Integrated Traditional Chinese and Western Medicine, Hunan Cancer Hospital, Changsha, Hunan, China.
这项研究揭示了GRPEL2作为一种通过破坏线粒体功能驱动结直肠癌 (CRC) 进展的瘤基因. 针对E2F8/GRPEL2/TIGAR途径为CRC提供了一个有前途的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 线粒体生物学 线粒体生物学
背景情况:
- 结肠直肠癌 (CRC) 是全球癌症死亡的主要原因.
- GRPEL2与线粒体调节和癌症有关,但其在CRC中的作用尚不清楚.
研究的目的:
- 阐明GRPEL2在CRC进展和线粒体调节中的作用.
- 在GRPEL2路径中识别潜在的治疗点.
主要方法:
- 对TCGA数据的RNA测序分析和qPCR验证.
- 细胞增殖,迁移和瘤发生的体外和体内测试.
- 使用各种染色和显微镜技术进行线粒体功能评估.
- 蛋白质与蛋白质相互作用研究 (LC-MS/MS,Co-IP) 和基因调节试验 (Luciferase,ChIP).
主要成果:
- 在CRC组织中,GRPEL2是上调调节的,并且与预后不佳有关.
- 抑制GRPEL2会通过线粒体损伤损害CRC细胞的增殖和迁移.
- TIGAR与GRPEL2相互作用,并且可以在抑制GRPEL2时挽救CRC进展.
- E2F8充当上游调节器,诱导CRC中的GRPEL2转录.
结论:
- 在CRC的发展中,GRPEL2起着致癌作用.
- E2F8/GRPEL2/TIGAR通路是CRC的一个关键分子机制.
- 这一途径代表了CRC治疗的新治疗标.
更多相关视频
07:59Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma
Published on: September 3, 2021
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
相关概念视频
Mitogens and the Cell Cycle
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal